Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients
Status:
Completed
Trial end date:
2019-03-30
Target enrollment:
Participant gender:
Summary
In this study (SNUG trial), the investigators aim to investigate the anti-pruritic effect of
PG102P in comparison with placebo in 80 patients undergoing HD.
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Boramae Hospital
Collaborators:
Chungnam National University Hospital DongGuk University Ewha Womans University Mokdong Hospital Gachon University Gil Medical Center Kyungpook National University Kyungpook National University Hospital Seoul National University Bundang Hospital Seoul National University Hospital Severance Hospital